Indius Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 1.43 Cr
as on 05-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 26.72%
(FY 2023)
- Profit 108.44%
(FY 2023)
- Ebitda 1344.60%
(FY 2023)
- Net Worth 0.69%
(FY 2023)
- Total Assets 0.51%
(FY 2023)
About Indius Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aditya Ingalhalikar, Nikhil Butala, Madhura Ingalhalikar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC164549
- Company No.
164549
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indius Medical Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Sathaye  | Additional Director | 17-Feb-2022 | Current |
| Aditya Ingalhalikar | Director | 17-May-2016 | Current |
| Nikhil Butala | Additional Director | 17-Feb-2022 | Current |
| Madhura Ingalhalikar | Director | 17-May-2016 | Current |
Financial Performance of Indius Medical Technologies.
Indius Medical Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.72% increase. The company also saw a substantial improvement in profitability, with a 108.44% increase in profit. The company's net worth moved up by a moderate rise of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indius Medical Technologies?
In 2023, Indius Medical Technologies had a promoter holding of 64.85% and a public holding of 35.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Market Trends Research FoundationActive 6 years 2 monthsAditya Ingalhalikar and Madhura Ingalhalikar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indius Medical Technologies?
Indius Medical Technologies has a workforce of 20 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indius Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indius Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
